Your email has been successfully added to our mailing list.

×
0 -0.0009514747859182 -0.0009514747859182 0 0 0.00761179828734534 -0.0133206470028544 -0.027592768791627
Stock impact report

Psyence Biomedical to not proceed with Clairvoyant acquisition [Seeking Alpha]

Psyence Biomedical Ltd. (PBM) 
Company Research Source: Seeking Alpha
PBM after hours to $0.103. Earlier in September, Psyence Biomedical said it has entered into a term sheet with privately held Clairvoyant Therapeutics to acquire 100% of its shareholding. Source: Press Release More on Psyence Biomedical Ltd. Psyence Biomedical receives delisting determination from Nasdaq Psyence Biomedical to acquire drug developer Clairvoyant Financial information for Psyence Biomedical Ltd. Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
PBM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PBM alerts
Opt-in for
PBM alerts

from News Quantified
Opt-in for
PBM alerts

from News Quantified